ASCO GU 2016

ASCO GU 2016

• January 21, 2016
• 1 min read

Research on prostate cancer shows that for patients who have undergone prostatectomy, follow-up investigations indicate that radiotherapy combined with Orally Disintegrating Tablets (OD tablets) is effective. Data sourced from ASCO GU 2016.

Key highlights include:

1. Clinical trial results for the addition of OD tablets following radiotherapy in patients who had their prostate removed.

2. The 10-year survival rate was higher in the OD tablet group due to a lower rate of metastasis.

3. Cardiac side effects were approximately twice as common, ranging from 2-3% to 4-6%.

Related data can be found at: http://meetinglibrary.asco.org/content/157474-172

#Prostate Cancer

Compliance: "Formerly certified by Japan's Ministry of Foreign Affairs and METI as an international medical visa guarantor (B-066)."

Copyright© Medical Supporter All rights reserved.

Figure 1

Figure 2

Figure 3

Figure 4